Chimerix

+$0.06 (+0.96%) As of 4:01 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Chimerix and other ETFs, options, and stocks.

About CMRX

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox.

CEO
Michael A. Sherman
Employees
54
Headquarters
Durham, North Carolina
Founded
2000

CMRX Key Statistics

Market cap
547.23M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.36M
High today
$6.30
Low today
$6.12
Open price
$6.26
Volume
85.13K
52 Week high
$11.57
52 Week low
$4.35

CMRX Earnings

-$0.41
-$0.27
-$0.14
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 24, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure